Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in icus a randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 312, Issue 14, 2014, Pages 1429-1437

  Oostdijk, Evelien A N ^a   Kesecioglu, Jozef ^a   Schultz, Marcus J ^b   Visser, Caroline E ^b   De Jonge, Evert ^c   Van Essen, Einar H R ^c   Bernards, Alexandra T ^c   Purmer, Ilse ^d   Brimicombe, Roland ^d   Bergmans, Dennis ^e   Van Tiel, Frank ^e   Bosch, Frank H ^f   Mascini, Ellen ^f   Van Griethuysen, Arjanne ^f   Bindels, Alexander ^g   Jansz, Arjan ^g   Van Steveninck, Fred A L ^h   Van Der Zwet, Wil C ^h   Fijen, Jan Willem ⁱ   Thijsen, Steven ⁱ   De Jong, Remko ^j   Oudbier, Joke ^k   Raben, Adrienne ^l   Van Der Vorm, Eric ^l   Koeman, Mirelle ^d   Rothbarth, Philip ^m   Rijkeboer, Annemieke ⁿ   Gruteke, Paul ⁿ   Hart Sweet, Helga ^o   Peerbooms, Paul ^o   Winsser, Lex J ^d   Van Elsacker Niele, Anne Marie W ^p   Demmendaal, Kees ^q   Brandenburg, Afke ^p   De Smet, Anne Marie G A ^r   Bonten, Marc J M ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Department of Intensive Care ^*

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RIJNSTATE HOSPITAL   (Netherlands)

^g CATHARINA HOSPITAL   (Netherlands)

^h DEVENTER HOSPITAL   (Netherlands)

ⁱ DEPARTMENT OF SURGERY   (Netherlands)

^j BovenIJ Ziekenhuis   (Netherlands)

^k ZAANS MEDICAL CENTER   (Netherlands)

^l GROENE HART HOSPITAL   (Netherlands)

^m RIJNLAND HOSPITAL   (Netherlands)

ⁿ Flevo Hospital   (Netherlands)

^o ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^p Centre for Infectious Diseases Friesland   (Netherlands)

^q NIJ SMELLINGHE HOSPITAL   (Netherlands)

^r UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIBIOTIC AGENT; CARBAPENEM; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC RESISTANT GRAM NEGATIVE BACTERIA; ARTICLE; BACTEREMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE CONTROL; DUTCHMAN; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE UNIT; INTENSIVE CARE UNIT ACQUIRED BACTEREMIA; LENGTH OF STAY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERIANAL SWAB; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT; SELECTIVE OROPHARYNGEAL DECONTAMINATION; TISSUE CULTURE; VERY ELDERLY; ADOLESCENT; CONTROLLED CLINICAL TRIAL; CROSS INFECTION; GASTROINTESTINAL TRACT; GRAM NEGATIVE INFECTION; MICROBIOLOGY; MIDDLE AGED; OROPHARYNX; RECTUM; STATISTICS; SURVIVAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; CROSS-OVER STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; GASTROINTESTINAL TRACT; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; OROPHARYNX; RECTUM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907698058     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.7247     Document Type: Article

References (20)

1. Bergmans DC, Bonten MJ, Gaillard CA, et al. Prevention of ventilator-associated pneumonia by oral decontamination: A prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2001;164(3):382-388.
2. de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomised controlled trial. Lancet. 2003;362(9389):1011-1016.
3. deSmet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009; 360(1):20-31.
4. Daneman N, Sarwar S, Fowler RA, Cuthbertson BH; SuDDICU Canadian Study Group. Effect of selective decontamination on antimicrobial resistance in intensive care units: A systematic review and meta-analysis. Lancet Infect Dis. 2013;13 (4):328-341.
5. Al Naiemi N, Heddema ER, Bart A, et al. Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother. 2006;58(4):853-856.
6. Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Van den broucke-Grauls CM. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother. 2013;57(7):3224-3229.
7. Higgins JP, White IR, Wood AM. Imputation methods formissing outcome data inmeta-analysis of clinical trials. Clin Trials. 2008;5(3):225-239.
8. Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012; 345:e5661.
9. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory andmystical. Lancet. 2005;365(9467):1348-1353.
10. Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection. 2005;33(5-6):309-313.
11. Heininger A, Meyer E, Schwab F, Marschal M, Unertl K, Krueger WA. Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance. Intensive Care Med. 2006; 32(10):1569-1576.
12. Leone M, Albanese J, Antonini F, Nguyen-Michel A, Martin C. Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Crit Care Med. 2003;31 (8):2090-2095.
13. Houben AJ, Oostdijk EA, van der Voort PH, Monen JC, Bonten MJ, van der Bij AK; ISIS-AR Study Group. Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: A 4 year ecological study in 38 intensive care units in the Netherlands. J Antimicrob Chemother. 2014;69(3):797-804.
14. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010; 156(pt 11):3216-3223.
15. Sommer MO, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science. 2009; 325(5944):1128-1131.
16. Buelow E, Gonzalez TB, Versluis D, et al. Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother. 2014; 69(8):2215-2223.
17. Oostdijk EA, Smits L, de Smet AM, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ. Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units. Intensive Care Med. 2013;39(4):653-660.
18. R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) website. http://www.r-gnosis.eu/Accessed July 29, 2014.
19. Oostdijk EA, de Smet AM, Kesecioglu J, Bonten MJ; Dutch SOD-SDD Trialists Group. The role of intestinal colonization with gram-negative bacteria as a source for intensive care unit-acquired bacteremia. Crit Care Med. 2011;39(5):961-966.
20. Oostdijk EA, deWit GA, Bakker M, de Smet AM, Bonten MJ; Dutch SOD-SDD Trialists Group. Selective decontamination of the digestive tract and selective oropharyngeal decontamination in intensive care unit patients: A cost-effectiveness analysis. BMJ Open. 2013;3(3):e002529.